Use of (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3- pyridazinyl)phenyl]hydrazono]propanedinitrile for the manufacture of a medicament for the treatment of coronary graft vasospasm

Use of (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3- pyridazinyl)phenyl]hydrazono]propanedinitrile, also known as levosimendan, or a pharmaceutically acceptable salts thereof in the manufacture of a medicament for the treatment or prevention of coronary graft vasospasm. Použitie (-)-[[4-(1,4,5,6-tet...

Full description

Saved in:
Bibliographic Details
Main Authors LEHTONEN LASSE, SZECSI JANOS, PAPP JULIUS
Format Patent
LanguageEnglish
Slovak
Published 04.01.2007
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Use of (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3- pyridazinyl)phenyl]hydrazono]propanedinitrile, also known as levosimendan, or a pharmaceutically acceptable salts thereof in the manufacture of a medicament for the treatment or prevention of coronary graft vasospasm. Použitie (-)-[[4-(1,4,5,6-tetrahydro-4-metyl-6-oxo-3- pyridazinyl)fenyl]hydrazono]propándinitrilu, známeho tiež ako levosimendan, alebo jeho farmaceuticky prijateľnej soli na výrobu lieku na liečbu alebo prevenciu vazospazmu koronárneho štepu.
Bibliography:Application Number: SK20010001934